Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 581732, 9 pages
http://dx.doi.org/10.1155/2014/581732
Research Article

Lentivirus-Mediated Nox4 shRNA Invasion and Angiogenesis and Enhances Radiosensitivity in Human Glioblastoma

1Department of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430030, China
2Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Jiefang Road 1095, Wuhan 430030, China

Received 2 February 2014; Revised 30 March 2014; Accepted 4 April 2014; Published 27 April 2014

Academic Editor: Xiaoqian Chen

Copyright © 2014 Yongsheng Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. DeAngelis, “Brain tumors,” The New England Journal of Medicine, vol. 344, no. 2, pp. 114–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Stupp, W. P. Mason, M. J. Van Den Bent et al., “Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma,” The New England Journal of Medicine, vol. 352, no. 10, pp. 987–996, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. D. Ray, B.-W. Huang, and Y. Tsuji, “Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling,” Cellular Signalling, vol. 24, no. 5, pp. 981–990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Block and Y. Gorin, “Aiding and abetting roles of NOX oxidases in cellular transformation,” Nature Reviews Cancer, vol. 12, no. 9, pp. 627–637, 2012. View at Publisher · View at Google Scholar
  5. T. Shono, N. Yokoyama, T. Uesaka et al., “Enhanced expression of NADPH oxidase Nox4 in human gliomas and its roles in cell proliferation and survival,” International Journal of Cancer, vol. 123, no. 4, pp. 787–792, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Senturk, M. Mumcuoglu, O. Gursoy-Yuzugullu, B. Cingoz, K. C. Akcali, and M. Ozturk, “Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth,” Hepatology, vol. 52, no. 3, pp. 966–974, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. Graham, M. Kulawiec, K. M. Owens et al., “NADPH oxidase 4 is an oncoprotein localized to mitochondria,” Cancer Biology and Therapy, vol. 10, no. 3, pp. 223–231, 2010. View at Google Scholar · View at Scopus
  8. U. Weyemi, B. Caillou, M. Talbot et al., “Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues,” Endocrine-Related Cancer, vol. 17, no. 1, pp. 27–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Yamaura, J. Mitsushita, S. Furuta et al., “NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression,” Cancer Research, vol. 69, no. 6, pp. 2647–2654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C.-H. Hsieh, W.-C. Shyu, C.-Y. Chiang, J.-W. Kuo, W.-C. Shen, and R.-S. Liu, “NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme,” PLoS ONE, vol. 6, no. 9, Article ID e23945, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. H. Hsieh, C. P. Wu, H. T. Lee, J. A. Liang, C. Y. Yu, and Y. J. Lin, “NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme,” Free Radical Biology and Medicine, vol. 53, no. 4, pp. 649–658, 2012. View at Publisher · View at Google Scholar
  12. T. W. Meijer, J. H. Kaanders, P. N. Span, and J. Bussink, “Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy,” Clinical Cancer Research, vol. 18, no. 20, pp. 5585–5594, 2012. View at Publisher · View at Google Scholar
  13. J. P. Lu, L. Monardo, I. Bryskin et al., “Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase,” Prostate Cancer and Prostatic Diseases, vol. 13, no. 1, pp. 39–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. P. Fitzgerald, B. Nayak, K. Shanmugasundaram et al., “Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production,” PLoS ONE, vol. 7, no. 1, Article ID e30712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Xia, Q. Meng, L.-Z. Liu, Y. Rojanasakul, X.-R. Wang, and B.-H. Jiang, “Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor,” Cancer Research, vol. 67, no. 22, pp. 10823–10830, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. E. V. Fletcher, L. Love-Homan, A. Sobhakumari, C. R. Feddersen, A. T. Koch, A. Goel et al., “EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC,” Molecular Cancer Research, vol. 11, no. 12, pp. 1574–1584, 2013. View at Publisher · View at Google Scholar
  17. P. O. Zinn, R. R. Colen, E. M. Kasper, and J. K. Burkhardt, “Extent of resection and radiotherapy in GBM: a 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients,” International Journal of Oncology, vol. 42, no. 3, pp. 929–934, 2013. View at Google Scholar
  18. L. Formentini, M. Sánchez-Aragó, L. Sánchez-Cenizo, and J. M. C. Cuezva, “The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response,” Molecular Cell, vol. 45, no. 6, pp. 731–742, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. A. Cerutti, “Prooxidant states and tumor promotion,” Science, vol. 227, no. 4685, pp. 375–381, 1985. View at Google Scholar · View at Scopus
  20. M. Landriscina, F. Maddalena, G. Laudiero, and F. Esposito, “Adaptation to oxidative stress, chemoresistance, and cell survival,” Antioxidants and Redox Signaling, vol. 11, no. 11, pp. 2701–2716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Pinthus, I. Bryskin, J. Trachtenberg et al., “Androgen induces adaptation to oxidative stress in prostate cancer: Implications for treatment with radiation therapy,” Neoplasia, vol. 9, no. 1, pp. 68–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Mariani, C. Beaudry, W. S. McDonough et al., “Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro,” Clinical Cancer Research, vol. 7, no. 8, pp. 2480–2489, 2001. View at Google Scholar · View at Scopus
  23. S. Y. Cho and R. L. Klemke, “Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix,” Journal of Cell Biology, vol. 149, no. 1, pp. 223–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Hiraga, M. Kato, S. Miyagawa, and T. Kamata, “Nox4-derived ROS signaling contributes to TGF-beta-induced epithelial-mesenchymal transition in pancreatic cancer cells,” Anticancer Research, vol. 33, no. 10, pp. 4431–4438, 2013. View at Google Scholar
  25. A. Kim, M. Im, N. H. Yim, Y. P. Jung, and J. Y. Ma, “Aqueous extract of bambusae caulis in taeniam inhibits PMA-induced tumor cell invasion and pulmonary metastasis: suppression of NF-κB activation through ROS signaling,” PLoS ONE, vol. 8, no. 10, Article ID e78061, 2013. View at Publisher · View at Google Scholar
  26. B. Zhang, Z. Liu, and X. Hu, “Inhibiting cancer metastasis via targeting NAPDH oxidase 4,” Biochem Pharmacol, vol. 86, no. 2, pp. 253–266, 2013. View at Publisher · View at Google Scholar
  27. W.-S. Wu, “The signaling mechanism of ROS in tumor progression,” Cancer and Metastasis Reviews, vol. 25, no. 4, pp. 695–705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Wild-Bode, M. Weller, A. Rimner, J. Dichgans, and W. Wick, “Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma,” Cancer Research, vol. 61, no. 6, pp. 2744–2750, 2001. View at Google Scholar · View at Scopus
  29. M. Zhang, S. Kleber, M. Röhrich et al., “Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma,” Cancer Research, vol. 71, no. 23, pp. 7155–7167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Arrillaga-Romany, D. A. Reardon, and P. Y. Wen, “Current status of antiangiogenic therapies for glioblastomas,” Expert Opinion on Investigational Drugs, vol. 23, no. 2, pp. 199–210, 2014. View at Publisher · View at Google Scholar
  31. S. Coso, I. Harrison, C. B. Harrison et al., “NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts,” Antioxidants and Redox Signaling, vol. 16, no. 11, pp. 1229–1247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Ushio-Fukai and Y. Nakamura, “Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy,” Cancer Letters, vol. 266, no. 1, pp. 37–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Sofia Vala, L. R. Martins, N. Imaizumi et al., “Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis,” PloS ONE, vol. 5, no. 6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. B. J. Moeller, Y. Cao, C. Y. Li, and M. W. Dewhirst, “Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules,” Cancer Cell, vol. 5, no. 5, pp. 429–441, 2004. View at Publisher · View at Google Scholar · View at Scopus